近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Li D, Tang X, Pulli B, Lin C, Zhao P, Cheng J, Lv Z, Yuan X, Luo Q, Cai H, Ye M. Theranostic nanoparticles based on bioreducible polyethylenimine-coated iron oxide for reduction-responsive gene delivery and magnetic resonance imaging. Int J Nanomedicine. 2014, 9: 3347-61. IF=4.32
Li D, Cai H, Hou M, Fu D, Ma Y, Luo Q, Yuan X, Lv M, Zhang X, Cong X, Lv Z. Effects of indoleamine 2,3-dioxygenases in carbon tetrachloride-induced hepatitis model of rats. Cell Biochem Funct. 2012 Jun;30(4): 309-14. IF=2.016
Xia W, Li D（并列第一）, Wang G, Ni J, Zhuang J, Ha M, Wang J, Ye Y. Small activating RNA upregulates NIS expression: promising potential for hepatocellular carcinoma endoradiotherapy. Cancer Gene Ther. 2016, Oct, 23(10): 333-340. IF=2.532。
Zhu X, Li D（并列第一）, Yu F, Jia C, Xie J, Ma Y, Fan S, Cai H, Luo Q, Lv Z, Fan L. MiR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein. Oncotarget. 2016, Mar 15, 7(11): 13139-13152. IF=5.008
Xie J, Yu F, Li D（并列第一）, Zhu X, Zhang X, Lv Z. MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2. Tumour Biol, 2016, Jan, 37(1): 1197-1204. IF=2.926
Yu F, Lv M, Li D（并列第一）, Cai H, Ma L, Luo Q, Yuan X, Lv Z. MiR-506 Over-Expression Inhibits Proliferation and Metastasis of Breast Cancer Cells. Med Sci Monit, 2015, Jun, 10, 21: 1687-1692. IF=1.405
Ye M, Li D（并列第一）, Yang J, Xie J, Yu F, Ma Y, Zhu X, Zhao J, Lv Z. MicroRNA-130a Targets MAP3K12 to Modulate Diabetic Endothelial Progenitor Cell Function. Cell Physiol Biochem. 2015, May, 36(2): 712-726. IF=4.652
Zhang X, Li D（并列第一）, Li M, Ye M, Ding L, Cai H, Fu D, Lv Z. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development. Int J Cancer. 2014, Jan, 15, 134(2):257-267. IF=5.531
Zuo K, Li D（并列第一）, Pulli B, Yu F, Cai H, Yuan X, Zhang X, Lv Z. Short-hairpin RNA-mediated Heat shock protein 90 gene silencing inhibits human breast cancer cell growth in vitro and in vivo. Biochem Biophys Res Commun. 2012, May, 4, 421(2): 396-402. IF=2.371
Hui Hua, Xiaoping Zhang, Dan Li（并列第一）, Jie Zou, Zhongwei Lv. Pharmacodynamics of julibroside J8 and J12 in inhibiting angiogenesis. Asian Biomedicine, 2011, Dec, 5(6): 755-763. IF=0.134
其他作者
Liu L, Yang J, Zhu X, Li D, Lv Z, Zhang X. Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer. FEBS J. 2016 Apr 19. doi: 10.1111/febs.13741.
Pulli B, Bure L, Wojtkiewicz GR, Iwamoto Y, Ali M, Li D, Schob S, Hsieh KL, Jacobs AH, Chen JW. Multiple sclerosis: myeloperoxidase immunoradiology improves detection of acute and chronic disease in experimental model. Radiology. 2015 May;275(2):480-9.
Han Y, Jia C, Cong X, Yu F, Cai H, Fang S, Cai L, Yang H, Sun Y, Li D, Liu J, Xie R, Yuan X, Zhong X, Li M, Wei Q, Lv Z, Fu D, Ma Y. Increased Expression of TGFβR2 Is Associated with the Clinical Outcome of Non-Small Cell Lung Cancer Patients Treated with Chemotherapy. PLoS One. 2015 Aug 7;10(8):e0134682.
Zhao G, Guo J, Li D, Jia C, Yin W, Sun R, Lv Z, Cong X. MicroRNA-34a suppresses cell proliferation by targeting LMTK3 in human breast cancer mcf-7 cell line. DNA Cell Biol. 2013, 32(12): 699-707.
Yu F, Lv M, Cai H, Li D, Yuan X, Lv Z. Therapeutic effect of 188Re-MAG3-depreotide on non-small cell lung cancer in vivo and in vitro. Int J Clin Exp Pathol. 2013, 6(3): 421-430.
Zhang X, Mao H, Chen JY, Wen S, Li D, Ye M, Lv Z. Increased expression of microRNA-221 inhibits PAK1 in endothelial progenitor cells and impairs its function via c-Raf/MEK/ERK pathway. Biochem Biophys Res Commun. 2013, 431(3): 404-408.
Zhang X, Li M, Zuo K, Li D, Ye M, Ding L, Cai H, Fu D, Fan Y, Lv Z. Upregulated miR-155 in Papillary Thyroid Carcinoma Promotes Tumor Growth by Targeting APC and Activating Wnt/β-Catenin Signaling. J Clin Endocrinol Metab. 2013, 98(8): E1305-1313.
Fu D, Cong X, Ma Y, Cai H, Cai M, Li D, Lv M, Yuan X, Huang Y, Lv Z.Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects. PLoS One. 2013, 8(2): e55727.
Yu F, Lü ML, Zhang XP, Fu D, Hou M, Cai HD, Li D, Wang J, Yuan XY, Lü ZW, Dong F. Pre-clinical evaluation of a new indirectly labeled 99mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator. Chin Med J (Engl). 2012, 125(14): 2538-2542.
Lv M, Xiaoping X, Cai H, Li D, Wang J, Fu X, Yu F, Sun M, Lv Z. Cytokines as prognstic tool in breast carcinoma. Front Biosci. 2011, 16: 2515-2526.
Zuo KQ, Zhang XP, Zou J, Li D, Lv ZW. Establishment of a paclitaxel resistant human breast cancer cell strain (MCF-7/Taxol) and intracellular paclitaxel binding protein analysis. J Int Med Res. 2010, 38(4): 1428-1435.
中文文章
通讯作者
张博佳，韦松华，陈炜，李丹。抑制NSCLC细胞株H1299中EIF5A2表达对肿瘤生长及转移的影响。同济大学学报（医学版），2017, 38(3): 30-34.
第一作者
李丹，张菁，白鑫，黄飚，张艺，吕中伟，屠红。新型肝癌标志物Glypican-3时间分辨免疫荧光法的建立。中华核医学杂志，2011,31（3）：201-204.
李丹，侯敏，吕中伟，吕明丽，蔡海东，余飞，孙明。（125）碘标记三链形成寡核苷酸对肝癌细胞中病毒复制和细胞生长的抑制作用。上海医学，2010,33（3）：290-294.
李丹，吕中伟。反基因技术用于肿瘤治疗的研究进展。同济大学学报（医学版），2008,29:84-90.
李丹，吕中伟。核医学显像在肿瘤诊断中的应用进展。中华医学与健康，2006,7:42-44.
李丹，黄飚，吕中伟。新型肝癌标志物Glypican-3时间分辨免疫荧光法的建立。中华医学会第九次全国核医学学术会议。2011-08-24.
李丹，林超，吕中伟。多模态磁性-荧光可降解纳米探针的研制及成像研究。中华医学会第九次全国核医学学术会议。2011-08-24.
其他作者
吕明丽，余飞，陆思琦，李丹，王舰，吕中伟。肥胖青年骨密度状况分析。同济大学学报（医学版），2012,33（4）：90-93.
余飞，吕明丽，蔡海东，李丹，吕中伟。基于双功能螯合剂的99mTc间接标记depreotide的探索。同济大学学报（医学版）,2012,33(3):10-16.
付兴建，王舰，吕明丽，李丹，吕中伟。基于MFC编程的图像处理在核医学中的应用。微计算机信息，2012, 4: 157-159.
王舰，蔡海东，吕明丽，付兴建，李丹，吕中伟。131I固定计量法及计算计量法治疗甲亢的疗效评价。同济大学学报（医学版），2012，33（1）:83-87.
余飞，吕明丽，蔡海东，李丹，袁雪宇，吕中伟。 血浆ANF与99mTc-DTPA肾动态显像的联合监测在糖尿病肾病中的意义。放射免疫学杂志。2013，26（01）：22-24.
吕明丽，余飞，陆思琦，王舰，李丹，吕中伟。肥胖青年骨密度状况分析。第五次全国青年核医学学术会议，2012-05-11.
余飞，吕明丽，蔡海东，李丹，袁雪宇，吕中伟。miR-506在乳腺肿瘤细胞增殖及转移中的作用。同济大学学报（医学版）2013，1:25-29.
余飞，吕明丽，蔡海东，李丹，袁雪宇，吕中伟。
京公网安备 11010802027423号